An optimized workflow for the integration of biological information into radiotherapy planning: experiences with T1w DCE-MRI

Planning of radiotherapy is often difficult due to restrictions on morphological images. New imaging techniques enable the integration of biological information into treatment planning and help to improve the detection of vital and aggressive tumour areas. This might improve clinical outcome. However, nowadays morphological data sets are still the gold standard in the planning of radiotherapy. In this paper, we introduce an in-house software platform enabling us to combine images from different imaging modalities yielding biological and morphological information in a workflow driven approach. This is demonstrated for the combination of morphological CT, MRI, functional DCE-MRI and PET data. Data of patients with a tumour of the prostate and with a meningioma were examined with DCE-MRI by applying pharmacokinetic two-compartment models for post-processing. The results were compared with the clinical plans for radiation therapy. Generated parameter maps give additional information about tumour spread, which can be incorporated in the definition of safety margins.

[2]  M V Knopp,et al.  Evaluation of angiogenesis and perfusion of bone marrow lesions: Role of semiquantitative and quantitative dynamic MRI , 1999, Journal of magnetic resonance imaging : JMRI.

[3]  G Brix,et al.  Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.

[4]  Charles R. Meyer,et al.  Mutual Information for Automated Unwarping of Rat Brain Autoradiographs , 1997, NeuroImage.

[5]  R. Lucht,et al.  Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.

[6]  Wolfhard Semmler,et al.  Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI , 2004, European Radiology.

[7]  Paul A. Viola,et al.  Multi-modal volume registration by maximization of mutual information , 1996, Medical Image Anal..

[8]  L R Schad,et al.  Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.

[9]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[10]  U. Haberkorn,et al.  PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Guy Marchal,et al.  Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.

[12]  Mark Rijpkema,et al.  Combined quantitative dynamic contrast‐enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer , 2004, Journal of magnetic resonance imaging : JMRI.

[13]  Gunnar Brix,et al.  Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience , 2001, European Radiology.

[14]  G Brix,et al.  Elastic matching of dynamic MR mammographic images , 2000, Magnetic resonance in medicine.

[15]  Mitchel S Berger,et al.  3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. , 2004, International journal of radiation oncology, biology, physics.

[16]  C. N. Coleman,et al.  Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it's time to get together again!). , 2003, Radiology.

[17]  Daniel B Vigneron,et al.  In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI , 2002, Journal of magnetic resonance imaging : JMRI.